A new study suggests that patients taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound may have inadequate bowel or stomach preparation before endoscopic procedures. The research found that these patients had higher instances of food remaining in the stomach or stool in the bowel, potentially impacting the effectiveness of endoscopies or colonoscopies. However, no serious complications such as aspiration occurred. More research is needed to assess if updated guidelines for GLP-1 use before these procedures are necessary.
GLP-1 weight-loss meds could interfere with endoscopy, colonoscopy (Medical Xpress)
0